Radiation therapy for T2N0 laryngeal cancer: A retrospective analysis for the impact of concurrent chemotherapy on local control

International Journal of Radiation Oncology Biology Physics

Volumn 64, Issue 4, 2006, Pages 995-1001

  Akimoto, Tetsuo ^a   Nonaka, Tetsuo ^a   Kitamoto, Yoshizumi ^b   Ishikawa, Hitoshi ^a   Ninomiya, Hiroshi ^a   Chikamatsu, Kazuaki ^a   Furuya, Nobuhiko ^a   Hayakawa, Kazushige ^c   Mitsuhashi, Norio ^d   Nakano, Takashi ^a  

^a GUNMA UNIVERSITY   (Japan)

^b GUNMA PREFECTURAL CANCER CENTER   (Japan)

^c KITASATO UNIVERSITY   (Japan)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Chemotherapy; Laryngeal cancer; Radiation therapy; Voice preservation

Indexed keywords

CHEMOTHERAPY; PATIENT TREATMENT; RADIOTHERAPY;

DISEASE-FREE SURVIVAL RATES; LARYNGEAL CANCER; VOICE PRESERVATION;

TUMORS;

CISPLATIN; DOCETAXEL;

ACUTE TOXICITY; ADULT; AGED; ANALYTIC METHOD; ARTICLE; BLOOD TOXICITY; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GLOTTIS; HUMAN; INTERMETHOD COMPARISON; LARYNX CANCER; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MUCOSA INFLAMMATION; MULTIVARIATE ANALYSIS; NEPHROTOXICITY; PREDICTION; PRIORITY JOURNAL; RECURRENCE RISK; RETROSPECTIVE STUDY; RISK FACTOR; SKIN MANIFESTATION; SURVIVAL RATE; TREATMENT RESPONSE; VOICE;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; GLOTTIS; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY DOSAGE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TAXOIDS; VOICE QUALITY;

EID: 33644538250     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.10.003     Document Type: Article

References (29)

1. W.M. Mendenhall, J.W. Werning, R.W. Hinerman Management of T1-T2 glottic carcinomas Cancer 100 2004 1786 1792
2. J.J. Beitler, J.T. Johnson Transoral laser excision for early glottic cancer Int J Radiat Oncol Biol Phys 56 2003 1063 1066
3. G. Back, S. Sood The management of early laryngeal cancer Options for patients and therapists Curr Opin Otolaryngol Head Neck Surg 13 2005 85 91
4. A.S. Garden, K. Forster, P.F. Wong Results of radiotherapy for T2N0 glottic carcinoma Does the "2" stand for twice-daily treatment? Int J Radiat Oncol Biol Phys 55 2003 322 328
5. E. Yu, G. Shenouda, M.P. Beaudet, M.J. Black Impact of radiation therapy fraction size on local control of early glottic carcinoma Int J Radiat Oncol Biol Phys 37 1997 587 591
6. O. Laccourreye, G. Weinstein, D. Brasnu Vertical partial laryngectomy A critical analysis of local recurrence Ann Otol Rhinol Laryngol 100 1991 68 71
7. K.T. Brumund, R. Gutierrez-Fonseca, D. Garcia Frontolateral vertical partial laryngectomy without tracheotomy for invasive squamous cell carcinoma of the true vocal cord A 25-year experience Ann Otol Rhinol Laryngol 114 2005 314 322
8. O. Laccourreye, E.M. Diaz Jr, V. Bassot A multimodal strategy for the treatment of patients with T2 invasive squamous cell carcinoma of the glottis Cancer 85 1999 40 46
9. Y. Kumamoto, M. Masuda, Y. Kuratomi "FAR" chemoradiotherapy improves laryngeal preservation rates in patients with T2N0 glottic carcinoma Head Neck 24 2002 637 642
10. R. Murakami, R. Nishimura, Y. Baba Prognostic factors of glottic carcinomas treated with radiation therapy Value of the adjacent sign on radiological examinations in the sixth edition of the UICC TNM staging system Int J Radiat Oncol Biol Phys 61 2005 471 475
11. L.H. Sobin, C. Wittekind TNM classification of malignant tumours 5th ed. 1997 Wiley-Liss New York
12. Y. Kitamoto, T. Akimoto, T. Nonaka Acute toxicity and preliminary clinical outcomes of concurrent radiation therapy and weekly docetaxel and daily cisplatin for head and neck cancer Jpn J Clin Oncol 35 2005 639 644
13. A. Trotti, R. Byhardt, J. Stetz Common toxicity criteria: Version 2.0. an improved reference for grading the acute effects of cancer treatment: Impact on radiotherapy Int J Radiat Oncol Biol Phys 47 2000 13 47
14. E.L. Kaplan, P.L. Meier Nonparametric estimation from incomplete observation J Am Stat Assoc 53 1958 457 481
15. D.R. Cox Regression model and life table (with discussion) J R Stat Soc 34 1972 187 220
16. K. Hayakawa, N. Mitsuhashi, T. Akimoto The effect of overall treatment time of radiation therapy on local control of T1-stage squamous cell carcinoma of the glottis Laryngoscope 106 1996 1545 1547
17. Y. Nishimura, Y. Nagata, K. Okajima Radiation therapy for T1, 2 glottic carcinoma Impact of overall treatment time on local control Radiother Oncol 40 1996 225 232
18. C.H. Terhaard, K. Snippe, L.A. Ravasz Radiotherapy in T1 laryngeal cancer Prognostic factors for locoregional control and survival, uni- and multivariate analysis Int J Radiat Oncol Biol Phys 21 1991 1179 1186
19. A.S. Jones, B. Fish, J.E. Fenton The treatment of early laryngeal cancers (T1-T2 N0) Surgery or irradiation? Head Neck 26 2004 127 135
20. K. Sakata, Y. Aoki, K. Karasawa Radiation therapy in early glottic carcinoma Uni- and multivariate analysis of prognostic factors affecting local control Int J Radiat Oncol Biol Phys 30 1994 1059 1064
21. K.A. Dinshaw, V. Sharma, J.P. Agarwal Radiation therapy in T1-T2 glottic carcinoma Influence of various treatment parameters on local control/complications Int J Radiat Oncol Biol Phys 48 2000 723 735
22. K.K. Fu, T.F. Pajak, A. Trotti A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas First report of RTOG 9003 Int J Radiat Oncol Biol Phys 48 2000 7 16
23. J.P. Pignon, J. Bourhis, C. Domenge MACH-NC Collaborative Group Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma Three meta-analyses of updated individual data Lancet 355 2000 949 955 Meta-Analysis of Chemotherapy on Head and Neck Cancer
24. V.A. Marcial, T.F. Pajak, M. Mohiuddin Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck Long-term results of the Radiation Therapy Oncology Group study 81-17 Cancer 66 1990 1861 1868
25. G.T. Wolf Commentary: Phase III trial to preserve the larynx: Induction chemotherapy and radiotherapy versus concurrent chemotherapy and radiotherapy versus radiotherapy-Intergroup trial R91-11 J Clin Oncol 19 Suppl. 18 2001 28S 31S
26. A.A. Forastiere, H. Goepfert, M. Maor Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer N Engl J Med 349 2003 2091 2098
27. J.D. Hainsworth, H.A. Burris 3rd, J.B. Erland Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer J Clin Oncol 16 1998 2164 2168
28. J.D. Hainsworth, H.A. Burris 3rd, F.A. Greco Weekly administration of docetaxel (Taxotere) Summary of clinical data Semin Oncol 26 Suppl. 10 1999 19 24
29. R. Mudad, M. Ramsey, K. Kovitz Concomitant weekly docetaxel, cisplatin and radiation therapy in locally advanced non-small cell lung cancer A dose finding study Lung Cancer 39 2003 173 177